Announcements Trials
Browse Landscape

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 3

Sponsor

Cancer Type

Gastrointestinal 3Sarcoma 2Thoracic 1Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Stomach Neoplasms 15Colorectal Neoplasms 15Pancreatic Neoplasms 11Colonic Neoplasms 9Carcinoma, Hepatocellular 9Esophageal Neoplasms 6Rectal Neoplasms 5Colorectal Neoplasms, Hereditary Nonpolyposis 4Anus Neoplasms 4Neoplasms 3Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Vulvar Neoplasms 2Uterine Cervical Neoplasms 2Squamous Intraepithelial Lesions 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Melanoma 2Endometrial Neoplasms 2Cholangiocarcinoma 2Bile Duct Neoplasms 2Acquired Immunodeficiency Syndrome 2Vaginal Neoplasms 1Urinary Bladder Neoplasms 1Skin Neoplasms 1Recurrence 1Pseudomyxoma Peritonei 1Prostatic Neoplasms 1Papillomavirus Infections 1

Interventions

Oxaliplatin 29Fluorouracil 25Leucovorin 20Capecitabine 18Irinotecan 17Surveys and Questionnaires 16Bevacizumab 14Cisplatin 12Blood Specimen Collection 11Drug Therapy 10Standard of Care 9Nivolumab 9Gemcitabine 9Cetuximab 7pembrolizumab 6Specimen Handling 6S 1 (combination) 6Endoscopic Mucosal Resection 6Cyclophosphamide 6atezolizumab 5Sunitinib 5Radiotherapy 5Folfox protocol 5Educational Status 5Docetaxel 5fludarabine 4aldesleukin 4Radiosurgery 4Pemetrexed 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Gastrointestinal Neoplasms × Observation × Gastrointestinal × Clear all
NCT05179824 2025-05-06

Tempus Priority Study: A Pan-tumor Observational Study

Tempus AI

Active not recruiting
1,000 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckLymphoidOther hematologic neoplasmSarcomaThoracic

Bile Duct Neoplasms, Urinary Bladder Neoplasms, Bone Neoplasms, Brain Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Fallopian Tube Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Skin Neoplasms, Stomach Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT05620537 2023-02-13

A Novel Nomogram to Predict the Postoperative Overall Survival in Gastrointestinal Cancer Patients

Jinling Hospital, China

Completed
808 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT00767234 2016-07-11

Permission to Collect Blood Over Time for Research

Stanford University

Terminated
104 enrolled
GastrointestinalSarcoma

Anus Neoplasms, Bile Duct Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡